Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| From COVID to fibrosis: lessons from single-cell analyses of the human lung. | Hum Genomics | 2022 | 35698166 | PubTator, text mining | PubMed |
| Differing coronavirus genres alter shared host signaling pathways upon viral infection. | Sci Rep | 2022 | 35697915 | PubTator, text mining | PubMed |
| The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancer. | Cell Death Discov | 2022 | 35697671 | PubTator, text mining | PubMed |
| Bone Morphogenetic Protein Signaling in Cancer; Some Topics in the Recent 10 Years. | Front Cell Dev Biol | 2022 | 35693928 | PubTator, text mining | PubMed |
| Regulatory Role and Potential Importance of GDF-8 in Ovarian Reproductive Activity. | Front Endocrinol (Lausanne) | 2022 | 35692411 | PubTator, text mining | PubMed |
| Heterotopic Mesenteric Ossification With Trilineage Hematopoiesis. | Cureus | 2022 | 35664416 | PubTator, text mining | PubMed |
| Hypoxia-induced inhibin promotes tumor growth and vascular permeability in ovarian cancers. | Commun Biol | 2022 | 35654828 | PubTator, text mining | PubMed |
Protocol paper: a multi-center, double-blinded, randomized, 6-month, placebo-controlled study followed by 12-month open label extension to evaluate the safety and efficacy of Saracatinib in Fibrodysplasia Ossificans Progressiva (STOPFOP). | BMC Musculoskelet Disord | 2022 | 35650602 | PubTator, text mining | PubMed |
| Complete and durable response to crizotinib in a patient with malignant pleural mesothelioma harboring CD74-ROS1 fusion. | J Cancer Res Clin Oncol | 2022 | 35648195 | PubTator, text mining | PubMed |
| Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions. | Arch Toxicol | 2022 | 35648190 | PubTator, text mining | PubMed |
| Mutational Screening of Skeletal Genes in 14 Chinese Children with Osteogenesis Imperfecta Using Targeted Sequencing. | J Immunol Res | 2022 | 35647203 | PubTator, text mining | PubMed |
| Convergent evolution and multi-wave clonal invasion in H3 K27-altered diffuse midline gliomas treated with a PDGFR inhibitor. | Acta Neuropathol Commun | 2022 | 35642016 | PubTator, text mining | PubMed |
| Bone morphogenetic protein signaling regulation of AMPK and PI3K in lung cancer cells and C. elegans. | Cell Biosci | 2022 | 35641992 | PubTator, text mining | PubMed |
| Overexpression of Wild-Type ACVR1 in Fibrodysplasia Ossificans Progressiva Mice Rescues Perinatal Lethality and Inhibits Heterotopic Ossification. | J Bone Miner Res | 2022 | 35637634 | PubTator, text mining | PubMed |
| Effects of BMSC-Derived EVs on Bone Metabolism. | Pharmaceutics | 2022 | 35631601 | PubTator, text mining | PubMed |
| Diffuse Intrinsic Pontine Glioma: Molecular Landscape, Evolving Treatment Strategies and Emerging Clinical Trials. | J Pers Med | 2022 | 35629262 | PubTator, text mining | PubMed |
| Iron Mining for Erythropoiesis. | Int J Mol Sci | 2022 | 35628152 | PubTator, text mining | PubMed |
| Plasma microRNAs as a Potential Biomarker for Identification of Progressive Supranuclear Palsy. | Diagnostics (Basel) | 2022 | 35626359 | PubTator, text mining | PubMed |
| Human-induced pluripotent stem cells-derived retinal pigmented epithelium, a new horizon for cells-based therapies for age-related macular degeneration. | Stem Cell Res Ther | 2022 | 35619143 | PubTator, text mining | PubMed |
| PROTAC mediated FKBP12 degradation enhances Hepcidin expression via BMP signaling without immunosuppression activity. | Signal Transduct Target Ther | 2022 | 35618726 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=31